Australia is eagerly awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://mariahwdib580456.wikibestproducts.com/2613797/this_new_drug_retatrutide_australia_a_new_hope_for_weight_management